Hepanit (70+250) Tablet | Price, Usage, Dosage, Composition, and Brand Substitutes - Fixed-Dose Combination (FDC) Drug
Hepanit (70+250) Tablet
Hepanit (70+250) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Mac Organics. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Silymarin, L-ornithine-L-Aspartate. This drug comes in the form of Tablet. The general packing available for this medicine consists of 10 Tablet and is priced at Rs 81 (arround $1.134 US Dollar)| Generic (Salt) Combination : | (Silymarin+ L-ornithine-L-Aspartate) |
| Pharma Company : | Mac Organics |
| Brand Label : | Hepanit (70+250) |
| Preparation Type : | Tablet |
| Single Dose : | 1 Tablet |
| Composition (Fixed-Dose Combination) : |
|
| Pack Size/Qty/Vol : | 10 Tablet |
| Price Unit : | Rs 8.1 INR (arround $0.1134 US Dollar) |
| Price Pack : | Rs 81 INR (arround $1.134 US Dollar) |
Drug details for Hepanit (70+250)
Usage: Why is this medication prescribed?
The main active ingredients or salts in Hepanit (70+250) are :
Silymarin
Indication (Prescribed for or used as): Hepatic disorders. Diabetes mellitus. Gall bladder disorders. Hyperlipedemia.
For more details on Silymarin, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Silymarin..
L-ornithine-L-AspartateIndication (Prescribed for or used as):
For more details on L-ornithine-L-Aspartate, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : L-ornithine-L-Aspartate..
Hepanit (70+250) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 2 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Hepanit (70+250), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Silymarin-70 mg L-ornithine-L-Aspartate-250 mg).Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.
| Brand | Price (Rs.) | Brand | Price (Rs.) |
| Arosi (70+250) | 90 | Liveraid (70+250) | 240 |